Out-Lab Therapy Approach Based on Elected A Restriction Enzyme to Transfer Target Gene
Al-Kitab Journal for Pure Sciences · 2022
DOI: 10.32441/kjps.02.02.p13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Al-Kitab Journal for Pure Sciences, 2022. Verfasst von Ayad Ghany Ismaeel. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
An important approach of therapy the target gene sequence causes diseases via repair/recombine the mutated gene (gene transfer) using a restriction enzymes in the laboratory. This approach will cause multiple problems happening accompany to biological laboratory if ruled out problems outside of it like the digested DNA ran as a smear on an agarose gel, incomplete restriction enzyme digestion, extra bands in the gel, etc. The paper suggested new approach of therapy via repair/replacement mutated gene caused disease by detecting primers and finding restriction enzymes using bioinformatics tools, software, packages etc. then achieving the repair/ recombine of mutations before going to the biologic lab (out-lab) to avoid the problems associated these laboratories. Implement and apply this a proposed therapy approach on TP53 gene (which caused more than 50% of human cancers) and after confirming there is mutations on P53 tumor protein shows an effective cost, friendly therapy methodology and comprehensive.
Zitieren
APA
Ismaeel, A. G. (2022). Out-Lab Therapy Approach Based on Elected A Restriction Enzyme to Transfer Target Gene. Al-Kitab Journal for Pure Sciences. https://doi.org/10.32441/kjps.02.02.p13
Vancouver
Ismaeel AG. Out-Lab Therapy Approach Based on Elected A Restriction Enzyme to Transfer Target Gene. Al-Kitab Journal for Pure Sciences. 2022. doi:10.32441/kjps.02.02.p13
BibTeX
@article{Ismaeel2022,
author = {Ismaeel, Ayad Ghany},
title = {Out-Lab Therapy Approach Based on Elected A Restriction Enzyme to Transfer Target Gene},
journal = {Al-Kitab Journal for Pure Sciences},
year = {2022},
doi = {10.32441/kjps.02.02.p13}
}
EUVIMED